Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02066051 · ClinicalTrials.gov registry record · NA
IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02066051: Completed NA study, sponsored by Mayo Clinic.
NCT02066051 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02066051, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study was to see if Intense Pulsed Light (IPL) can be used safely and effectively to help treat dry eyes from ocular rosacea after chronic graft-versus-host disease (GVHD). Current treatment options for this disease are limited.
Primary Outcome
Participants received treatment over 4 months and were monitored for safety and response for an additional 8 months. The symptoms were scored with the Standard Patient Evaluation of Eye Dryness (SPEED2) questionnaire. The SPEED questionnaire presents the four most commonly experienced dry eye symptom groups and asks patients to tick a box for all symptoms that apply to them. The frequency section ratings run from 0 (never) to 3 (constant), and the severity section ratings run from 0 (no problems
Interventions
- PROCEDURE Meibomian Gland Expression
- DEVICE IPL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-11 |
| Phase | NA |
What the finished NCT02066051 record still lists
NCT02066051 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Meibomian Gland Expression is the first listed.
NCT02066051 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02066051 about?
NCT02066051 is a clinical study titled "IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD". The purpose of this study was to see if Intense Pulsed Light (IPL) can be used safely and effectively to help treat dry eyes from ocular rosacea after chronic graft-versus-host disease (GVHD). Current treatment options for this disease are limited.
What is the current status of trial NCT02066051?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2013-10. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02066051?
The interventions under investigation include: Meibomian Gland Expression (PROCEDURE), IPL (DEVICE).
Who is sponsoring clinical trial NCT02066051?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02066051's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia